Levi Garraway is joining Eli Lilly (NYSE: LLY) as senior vice president, global development and medical affairs, of the company’s oncology unit. Garraway is currently director of the Joint Center for Cancer Precision Medicine at the Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Boston Children’s Hospital, and the Broad Institute. He is also a professor of medicine at Dana-Farber and Harvard Medical School. Garraway will succeed Richard Gaynor, who is retiring from the Indianapolis-based company. Garraway will start his new post on Jan. 1.